TUMOREND, LLC

Basic Information

755 DELGADO DR
BATON ROUGE, LA, 70808-4731

Company Profile

n/a

Additional Details

Field Value
DUNS: 830787011
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Immunoassay for diagnosis of invasive fungal disease

    Amount: $149,043.00

    DESCRIPTION: We have preliminary data for a small molecule glyco-decoy that specifically side-tracks the biosynthesis of the ligand for E-selection, and is a candidate for a novel anti-inflammatory. T ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Structure-Activity Relationship of CM101 Tumor antiangiogenic agent with its lect

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): CM101 is a polysaccharide tumor angiogenesis-targeting, complement activating, immune stimulating biological produced fermentatively from Group B Streptococcus. CM ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government